I

Inno-Gene SA
WSE:IGN

Watchlist Manager
Inno-Gene SA
WSE:IGN
Watchlist
Price: 5.04 PLN -0.4%
Market Cap: 17.7m PLN
Have any thoughts about
Inno-Gene SA?
Write Note

Inno-Gene SA
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Inno-Gene SA
Total Equity Peer Comparison

Comparables:
M
MDB
R
RVU
S
SLV

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
I
Inno-Gene SA
WSE:IGN
Total Equity
zł2.8m
CAGR 3-Years
-31%
CAGR 5-Years
3%
CAGR 10-Years
16%
M
Medicofarma Biotech SA
WSE:MDB
Total Equity
zł12.6m
CAGR 3-Years
N/A
CAGR 5-Years
65%
CAGR 10-Years
N/A
R
Ryvu Therapeutics SA
WSE:RVU
Total Equity
zł205.4m
CAGR 3-Years
2%
CAGR 5-Years
N/A
CAGR 10-Years
43%
S
Selvita SA
WSE:SLV
Total Equity
zł316.1m
CAGR 3-Years
24%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Inno-Gene SA's Total Equity?
Total Equity
2.8m PLN

Based on the financial report for Jun 30, 2024, Inno-Gene SA's Total Equity amounts to 2.8m PLN.

What is Inno-Gene SA's Total Equity growth rate?
Total Equity CAGR 10Y
16%

Over the last year, the Total Equity growth was -62%. The average annual Total Equity growth rates for Inno-Gene SA have been -31% over the past three years , 3% over the past five years , and 16% over the past ten years .

Back to Top